17-Jul-2026
No headlines found.
Colony Bankcorp, Inc. Announces Date for Second Quarter 2026 Earnings Release and Conference Call
Business Wire (Mon, 6-Jul 8:30 AM ET)
Are APGE, INVE, CBAN, FSRL Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 2-Jul 3:38 PM ET)
Business Wire (Mon, 29-Jun 4:23 PM ET)
KBRA Comments on Colony Bancorp, Inc.'s Proposed Merger with First Reliance Bancshares, Inc.
Business Wire (Fri, 26-Jun 5:30 PM ET)
PRNewswire (Thu, 25-Jun 1:42 PM ET)
Business Wire (Thu, 25-Jun 5:54 AM ET)
Business Wire (Wed, 24-Jun 5:00 PM ET)
Colony Bankcorp, Inc. Reports First Quarter 2026 Results
Business Wire (Wed, 22-Apr 4:15 PM ET)
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
Colony Bankcorp trades on the NYSE stock market under the symbol CBAN.
As of July 17, 2026, CBAN stock price declined to $20.98 with 285,055 million shares trading.
CBAN has a beta of 0.21, meaning it tends to be less sensitive to market movements. CBAN has a correlation of 0.01 to the broad based SPY ETF.
CBAN has a market cap of $444.07 million. This is considered a Small Cap stock.
Last quarter Colony Bankcorp reported $40 million in Revenue and $.45 earnings per share. This fell short of revenue expectation by $-549,000 and missed earnings estimates by -$.02.
In the last 3 years, CBAN traded as high as $21.61 and as low as $9.36.
The top ETF exchange traded funds that CBAN belongs to (by Net Assets): VTI, IWM, AVUV, VXF, IWN.
CBAN has outperformed the market in the last year with a price return of +21.4% while the SPY ETF gained +19.5%. However, in the short term, CBAN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.7% vs +4.9% return in SPY. But in the last 2 weeks, CBAN shares have fared better than the market returning +3.7% compared to SPY -0.2%.
CBAN support price is $21.02 and resistance is $21.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBAN shares will trade within this expected range on the day.
